In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you ...

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...

Mounjaro has been approved for both type 2 diabetes and weight loss; however, access will be limited by strict eligibility ...

A Drug box of Ozempic containing Semaglutide for treatment of type 2 diabetes and long-term weight management on a table and ...

Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...

Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...

WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...

A GP shares her journey using using GLP-1 medication as primary care prescribing of tirzepatide for obesity begins this week.

The 0.25mg, 0.5mg and 1mg dosage of Wegovy will cost ₹17,345 for a month. A higher dose form of 1.75mg will cost ₹24,280 a month, while 2.4mg dose will be for ₹26,050. The drug follows a four-week ...

TUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to ...

It’s a shot at better health that comes with a promise to help shed the pounds. Demand for drugs like Ozempic, Wegovy, Mounjaro and Zepbound continues to grow. FILE – Donna ...